Patients’ knowledge about psoriasis and comorbidities; their participation in treatment decisions

dc.contributor.authorCingöz K.
dc.contributor.authorGündüz K.
dc.contributor.authorİnanır I.
dc.date.accessioned2024-07-22T08:06:47Z
dc.date.available2024-07-22T08:06:47Z
dc.date.issued2021
dc.description.abstractBackground: Psoriasis is a common chronic inflammatory disease. Having more information about psoriasis and comorbid diseases means that patients have more involvement in treatment. Aim: Evaluate the knowledge levels of psoriasis patients about the disease and comorbidities and also to determine participation in treatment decisions. Methods: Totally 103 patients over the age of 18 with diagnosed psoriasis were included into the study. A questionnaire including items on knowledge about disease and treatment options, comorbid diseases were filled out by the patients. Total knowledge score (TKS) was found by giving 1 point to the questions that the patients knew correctly. Results: Patients were well informed about their risk of depression (64.1%), but were less well informed about their risk of atherothrombotic disease (14.6%). About 50.4% of the patients thought that psoriasis may be due to an internal organ disease. There was a negative correlation between the patient’s age, the age of diagnosis and TKS. About 42.7% wanted to leave the decision entirely to the physician. Conclusion: The results of this study showed that majority of patients with psoriasis are not aware of the increased risk of comorbid diseases and do not have enough knowledge about psoriasis. © 2019 Taylor & Francis Group, LLC.
dc.identifier.DOI-ID10.1080/09546634.2019.1638880
dc.identifier.issn09546634
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/13690
dc.language.isoEnglish
dc.publisherTaylor and Francis Ltd.
dc.subjectAdult
dc.subjectAged
dc.subjectAged, 80 and over
dc.subjectComorbidity
dc.subjectDecision Making
dc.subjectFemale
dc.subjectHumans
dc.subjectKnowledge
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectPatients
dc.subjectPsoriasis
dc.subjectSurveys and Questionnaires
dc.subjectYoung Adult
dc.subjectbiological product
dc.subjectcorticosteroid
dc.subjectsteroid
dc.subjectadult
dc.subjectaged
dc.subjectArticle
dc.subjectbiological therapy
dc.subjectclinical evaluation
dc.subjectcomorbidity
dc.subjectcontrolled study
dc.subjectcorticosteroid therapy
dc.subjectdepression
dc.subjectfemale
dc.subjecthuman
dc.subjectinflammatory disease
dc.subjectknowledge
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectpatient attitude
dc.subjectphototherapy
dc.subjectphysician
dc.subjectpriority journal
dc.subjectpsoriasis
dc.subjectquestionnaire
dc.subjectrisk factor
dc.subjectscoring system
dc.subjectshared decision making
dc.subjectthrombosis
dc.subjecttopical treatment
dc.subjecttotal knowledge score
dc.subjectcomorbidity
dc.subjectdecision making
dc.subjectmiddle aged
dc.subjectpathology
dc.subjectpatient
dc.subjectpsoriasis
dc.subjectpsychology
dc.subjectvery elderly
dc.subjectyoung adult
dc.titlePatients’ knowledge about psoriasis and comorbidities; their participation in treatment decisions
dc.typeArticle

Files